Skip to main content
Article thumbnail
Location of Repository

The development of a bioreactor to perfuse radially-confined hydrogel constructs: design and characterization of mass transport properties

By Joshua O. Eniwumide, David A. Lee and Dan L. Bader


Limitations to nutrient transport provide a challenge to the development of 3D tissue-engineered constructs. A heterogeneous distribution of viable cells and functional matrix within the developing tissue is a common consequence. In the present study, a bioreactor was developed to perfuse fluid through cylindrical agarose constructs. The transport and distribution of dextran molecules (FD-4, FD-500, FD-2000) within the agarose was visualized in order to determine the bioreactors effectiveness for transport enhancement. By 24 h, the perfusion bioreactor achieved 529%, 395% and 294% higher concentrations of FD-4, FD-500 and FD-2000, respectively, than those solely due to diffusion. Of particular interest was the effectiveness of the bioreactor to transport molecules to the central region of the constructs. In this respect, the perfusion bioreactor was found to increase transportation of FD-4, FD-500 and FD-2000 by 30%, 291% and 222% over that of diffusion. Articular chondrocytes were cultured and perfused using the bioreactor. The improved molecular transport achieved led to an average 75% and 1340% increase of DNA and sulphated GAG, respectively at 20 days. More significantly was the 106% and 1603% increase of DNA and GAG, respectively, achieved at the central core of the 3D construct

Topics: R1
Year: 2009
OAI identifier:
Provided by: e-Prints Soton

Suggested articles


  1. (1982). A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures, doi
  2. (1985). A mathematical-model for restricted diffusion effects on macromolecule impregnation in porous supports, doi
  3. (2002). Advanced bioreactor with controlled application of multi-dimensional strain for tissue engineering, doi
  4. (2006). Analysis of cell growth and diffusion in a scaffold for cartilage tissue engineering, doi
  5. (1991). Arthroscopic lavage of osteoarthritic knees,
  6. (2006). Articular cartilage paste grafting to full-thickness articular cartilage knee joint lesions: a 2- to 12-year follow-up, doi
  7. (2007). Autologous chondrocyte implantation in chondral defects of the knee with a type I/III collagen membrane: a prospective study with a 3-year follow-up, doi
  8. (1999). Biologic repair of articular cartilage. Defect models in experimental animals and matrix requirements, doi
  9. (2006). Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors, doi
  10. (1997). Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds, doi
  11. (2006). C.A.Chung,C.W.YangandC.W.Chen,Analysisofcell growthanddiffusioninascaffoldforcartilage tissue engineering,
  12. (2003). Cartilage tissue engineering using cryogenic chondrocytes, doi
  13. (1986). Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions, doi
  14. (2004). Cellular utilization determines viability and matrix distribution profiles in chondrocyte-seeded alginate constructs, doi
  15. (1998). Chondrogenesis in a cell–polymer-bioreactor system, Exp. Cell Res. doi
  16. (2000). Comparison of chondrogensis in static and perfused bioreactor culture, doi
  17. (1934). Concerning the shape of thread shapes molecules in solution,
  18. (2003). Development and validation of a bioreactor for physical stimulation of engineered cartilage,
  19. (1999). Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations, doi
  20. (2004). Effect of hindered diffusion on the adsorption of proteins in agarose gel using a pore model, doi
  21. (2005). Effects of FGF-2 and IGF-1 on adult canine articular chondrocytes in type II collagenglycosaminoglycan scaffolds in vitro, doi
  22. (1993). Effects of intra-articular chlorhexidine diacetate lavage on the stifle in healthy dogs,
  23. (1997). Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts, doi
  24. (2004). Fluid flow and convective transport of solutes within the intervertebral disc, doi
  25. (2004). Fluid mechanics of a spinner-flask bioreactor, doi
  26. (1988). Fluorometric assay of DNA in cartilage explants using Hoechst 33258, doi
  27. (2003). Functional assessment of tissue-engineered meniscal cartilage by magnetic resonance imaging and spectroscopy, doi
  28. (1998). Growing tissues in microgravity, doi
  29. (2000). Growth of tissue-engineered human nasoseptal cartilage in simulated microgravity, doi
  30. (2005). Heterogeneous proliferation within engineered cartilaginous tissue: the role of oxygen tension, doi
  31. (2006). Influence of perfusion on metabolism and matrix production by bovine articular chondrocytes in hydrogel scaffolds, doi
  32. (1999). Method for quantitative analysis of glycosaminoglycan distribution in cultured natural and engineered cartilage, doi
  33. (1993). Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers, doi
  34. (1982). Nutrition of the intervertebral disc: effect of fluid flow on solute transport, doi
  35. (1981). Nutrition of the intervertebral disc: solute transport and metabolism, doi
  36. (1977). Nutrition of the intervertebral disk. An in vivo study of solute transport, doi
  37. (1999). Obradovic et al., Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage, doi
  38. (2003). Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity, doi
  39. (2004). Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: measurement and modeling, doi
  40. (2002). Perfusion increases cell content and matrix synthesis in chondrocyte threedimensional cultures, doi
  41. (1997). Pore size of agarose gels by atomic force microscopy, doi
  42. (2005). Proliferation and differentiation potential of chondrocytes from osteoarthritic patients,
  43. (2000). Scaffolds in tissue engineering bone and cartilage, doi
  44. (2000). The reactions of articular cartilage to experimental wounding: role of apoptosis, doi
  45. (2002). Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes, doi
  46. (1976). Transport of solutes through cartilage: permeability to large molecules,
  47. (1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation, doi
  48. (1998). Visualising intraparticle protein transport in porous adsorbents by confocal microscopy, doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.